Allen Capital Group LLC Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Allen Capital Group LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 17.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,731 shares of the healthcare conglomerate's stock after acquiring an additional 1,879 shares during the quarter. Allen Capital Group LLC's holdings in UnitedHealth Group were worth $6,668,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of UNH. Trust Investment Advisors grew its holdings in UnitedHealth Group by 7.8% during the first quarter. Trust Investment Advisors now owns 3,441 shares of the healthcare conglomerate's stock worth $1,802,000 after buying an additional 249 shares in the last quarter. Altman Advisors Inc. raised its holdings in shares of UnitedHealth Group by 4.2% in the first quarter. Altman Advisors Inc. now owns 3,232 shares of the healthcare conglomerate's stock valued at $1,693,000 after purchasing an additional 129 shares during the last quarter. SeaBridge Investment Advisors LLC purchased a new stake in shares of UnitedHealth Group in the first quarter valued at about $204,000. Cable Hill Partners LLC raised its holdings in shares of UnitedHealth Group by 29.6% in the first quarter. Cable Hill Partners LLC now owns 2,736 shares of the healthcare conglomerate's stock valued at $1,433,000 after purchasing an additional 625 shares during the last quarter. Finally, Parcion Private Wealth LLC raised its holdings in shares of UnitedHealth Group by 3.2% in the first quarter. Parcion Private Wealth LLC now owns 1,199 shares of the healthcare conglomerate's stock valued at $628,000 after purchasing an additional 37 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction dated Friday, May 16th. The stock was purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer owned 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO John F. Rex acquired 17,175 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the purchase, the chief financial officer owned 203,796 shares of the company's stock, valued at $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. Mizuho decreased their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a report on Friday, May 16th. TD Cowen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a research report on Monday, May 19th. TD Securities restated a "hold" rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Piper Sandler lowered their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a report on Tuesday, June 3rd. Finally, JPMorgan Chase & Co. upped their price target on shares of UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a report on Friday, June 20th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $394.43.

UnitedHealth Group Stock Performance

Shares of UNH traded down $6.82 on Friday, reaching $281.25. The company's stock had a trading volume of 8,055,353 shares, compared to its average volume of 7,774,821. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market capitalization of $255.13 billion, a P/E ratio of 11.79, a PEG ratio of 1.42 and a beta of 0.45. The stock's 50 day simple moving average is $306.43 and its two-hundred day simple moving average is $434.93. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the business earned $6.91 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 3.14%. The ex-dividend date was Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is currently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.